Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder

NCT06969937 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
75
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dr. med. Marcus Herdener

Collaborators